Grossman Fred
President and Chief Medical Officer
Dermatology
Reactor Monitoring and Simulation Laboratory
Russian Federation
Biography
Dr. Fred Grossman, DO, FAPA is President and Chief Medical Officer of Glenmark Pharmaceuticals Ltd. He oversees global clinical development, pharmacovigilance, medical affairs and clinical operations for innovative product development, as well as specialty and generic products. In this role, he furthers Glenmark’s investments in research to generate assets that address unmet medical needs in a variety of therapeutic areas. Dr. Grossman has more than 20 years of international experience directing research and development for potential new medicines for leading pharmaceutical organizations. Before joining Glenmark in 2015, he held global medical leadership positions at Eli Lilly, Johnson & Johnson, Bristol-Myers Squibb, and Sunovion. Dr. Grossman is a board-certified physician, completed a fellowship in pharmacology at the National Institutes of Health, has several academic appointments and is the author of numerous scientific publications. He received his medical degree from Hahnemann University in Philadelphia, Pennsylvania.
Research Interest
His research areas of interests are Dermatology and Cosmetology
